Siemens Artis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Siemens artis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Siemens Artis Today - Breaking & Trending Today

Alexa as EKG; Post-COVID Clot Prevention; Retinal Artery Stroke Guidance


email article
Smart home speakers like Amazon Echo can be used to monitor heart rhythms by sonar, researchers report in
Communications Biology.
The ACTIV-4 Convalescent trial is now underway testing apixaban (Eliquis) for thromboprophylaxis after discharge for moderate-to-severe COVID-19, the NIH announced.
Even if heart failure stabilizes without improving on cardiac resynchronization therapy, 5-year prognosis is much better than was thought, suggesting that the current convention of nonresponder classification should be modified, according to a REVERSE trial analysis. (
JACC: Clinical Electrophysiology)
The 4PEPS tool safely ruled out pulmonary embolism solely on clinical criteria and optimized D-dimer measurement, while substantially reducing imaging tests. ( ....

New York , United States , United Kingdom , Siemens Artis , Nature Communications , Kidney International , American Heart Association , New York Post , Health Affairs , Institute For Clinical , University Of Iowa Muscatine Heart Study , Communications Biology , Amazon Echo , Clinical Electrophysiology , Controlrad Select , Muscatine Heart Study , Prince Philip , Economic Review , Cerebrovascular Accident , Ischemic Stroke , Abnormal Vision , Kidney Disease , Visual Impairment , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

ControlRad Announces FDA Clearance for ControlRad Select


ControlRad Announces FDA Clearance for ControlRad Select
ATLANTA, March 4, 2021 /PRNewswire/ ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select. The technology utilizes proprietary semi-transparent filters, a user-interface tablet, and image processing algorithms, which are retrofitted onto customers existing Siemens Artis zee interventional imaging systems.
In preparation for the commercialization efforts, ControlRad has entered into an exclusive agreement with Boston Scientific Corporation to sell the ControlRad Select technology.
With the FDA clearance and the reach of the global medical device sales team, every cath, EP, and IR lab in the country that has a Siemens Artis zee will now have the opportunity to reduce their radiation dose by 85% ....

United States , Kfar Saba , Royal Oak , Siemens Artis , Kostenloser Wertpapierhandel , Guillaume Bailliard , Simon Dixon , Boston Scientific Corporation , Prnewswire Controlrad Inc , Drug Administration , Controlrad Select , Beaumont Hospital , ஒன்றுபட்டது மாநிலங்களில் , க்பர் சபா , அரச ஓக் , ஸீமெந்ஸ் கலைஞர்கள் , சிமோன் டிக்சன் , போஸ்டன் அறிவியல் நிறுவனம் , பியூமான்ட் மருத்துவமனை ,